Early changes in gene expression profiles in AML patients during induction chemotherapy

BACKGROUND: Elucidation of the genetic mechanisms underlying treatment response to standard induction chemotherapy in AML patients is warranted, in order to aid in risk-adapted treatment decisions as novel treatments are emerging. In this pilot study, we explored the treatment-induced expression pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Ingrid, Sundkvist, Max, Björn, Niclas, Gréen, Henrik, Lotfi, Kourosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664790/
https://www.ncbi.nlm.nih.gov/pubmed/36376859
http://dx.doi.org/10.1186/s12864-022-08960-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9664790/
https://www.ncbi.nlm.nih.gov/pubmed/36376859
http://dx.doi.org/10.1186/s12864-022-08960-4

Ejemplares similares